BioSurface Engineering Technologies
Latest round
- Series C
Last raised
- Mar 2007
Total raised
- $14M
Investors
- 9
About BioSurface Engineering Technologies
Founded in 2001 and based in Maryland, US, BioSurface Engineering Technologies develops proprietary therapeutic peptides as medical devices to improve bone and soft tissue repair.
Who invested in BioSurface Engineering Technologies
9 investors across 2 rounds
See all investors in BioSurface Engineering Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BioSurface Engineering Technologies
Who invested in BioSurface Engineering Technologies?
BioSurface Engineering Technologies has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioSurface Engineering Technologies raised?
BioSurface Engineering Technologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did BioSurface Engineering Technologies last raise money?
BioSurface Engineering Technologies's most recent round on record is a Series C, in Mar 2007.
What does BioSurface Engineering Technologies do?
Founded in 2001 and based in Maryland, US, BioSurface Engineering Technologies develops proprietary therapeutic peptides as medical devices to improve bone and soft tissue repair.
Where is BioSurface Engineering Technologies headquartered?
BioSurface Engineering Technologies is headquartered in Rockville, US.
Which VCs invest in companies like BioSurface Engineering Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at BioSurface Engineering Technologies's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like BioSurface Engineering Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.